Literature DB >> 6978728

Distribution of T-lymphocyte subsets in Hodgkin's disease characterized by monoclonal antibodies.

M S Dorreen, J A Habeshaw, P F Wrigley, T A Lister.   

Abstract

Mononuclear-cell suspensions of lymph nodes, spleen and blood from 24 patients with active Hodgkin's disease (HD) were studied for possible imbalance of T and B lymphocytes, and T-lymphocyte subsets, using monospecific anti-T antibodies and other reagents. A profile showing T-cell predominance was demonstrated in lymph nodes and blood, with total T-cells ranging from 50-70% of the cell count. As defined by monoclonal antibodies, 70-85 of the latter comprised the "inducer" subclass, the remainder being "suppressor" cells. There were no essential differences between histologically involved and uninvolved lymph nodes from HD patients, though total T-cell proportions were lower in "normal lymph node" controls. The profiles of spleens electively removed, as part of pre-treatment staging procedures, showed reduced total T-cell numbers, whether these were involved with HD or not. These differences are accounted for principally by fewer T "inducer" cells (24%, in spleen, v. 54% in involved lymph nodes and 47% in "normal" control nodes). Possible explanations for these findings are discussed. Our results demonstrate similar profiles in histologically diseased and normal tissue, rather than any clear imbalance of T-cell proportions which might explain the profound disturbances of T-cell function frequently demonstrated in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6978728      PMCID: PMC2010995          DOI: 10.1038/bjc.1982.84

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

Review 1.  Suppressor T cells.

Authors:  R W Dutton
Journal:  Transplant Rev       Date:  1975

2.  Immune alterations in Hodgkin's disease. Effect of delayed hypersensitivity and lymphocyte transformation on course and survival.

Authors:  R C Young; M P Corder; C W Berard; V T DeVita
Journal:  Arch Intern Med       Date:  1973-03

3.  Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.

Authors:  J R Eltringham; H S Kaplan
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

4.  Increase of T lymphocytes in the spleen in Hodgkin's disease.

Authors:  J Kaur; A S Spiers; D Catovsky; D A Galton
Journal:  Lancet       Date:  1974-10-05       Impact factor: 79.321

5.  Specific suppression of immune responses.

Authors:  D A Rowley; F W Fitch; F P Stuart; H Köhler; H Cosenza
Journal:  Science       Date:  1973-09-21       Impact factor: 47.728

6.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

7.  Impaired lymphocyte function in untreated Hodgkin's disease.

Authors:  R Levy; H S Kaplan
Journal:  N Engl J Med       Date:  1974-01-24       Impact factor: 91.245

8.  Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.

Authors:  A M Bobrove; Z Fuks; S Strober; H S Kaplan
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

9.  The pathology and nomenclature of Hodgkin's disease.

Authors:  R J Lukes; J J Butler
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

10.  Immunologic deficiency in Hodgkin's disease.

Authors:  J E Sokal
Journal:  Tumori       Date:  1973 Sep-Oct
View more
  14 in total

1.  Absence of HLA class I expression by Reed-Sternberg cells.

Authors:  S Poppema; L Visser
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

Review 2.  The role of the spleen in leukemias and lymphomas including Hodgkin's disease.

Authors:  R Maurer
Journal:  Experientia       Date:  1985-02-15

3.  Reed-Sternberg/lymphocyte rosette: lymphocyte subpopulations as defined by monoclonal antibodies.

Authors:  C S Morris; A E Stuart
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

4.  Cells which contain S-100 protein in Hodgkin's disease: a quantitative study.

Authors:  G Sangster; J Crocker; R Jenkins; M J Leyland
Journal:  J Clin Pathol       Date:  1985-09       Impact factor: 3.411

5.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10

6.  Intrahepatic distribution of T cell and T cell subsets in cases with type B chronic liver disease by peroxidase-labeled antibody method using monoclonal antibodies.

Authors:  T Nishihara
Journal:  Gastroenterol Jpn       Date:  1983-08

7.  Subsets of blood, spleen and recirculating lymphocytes in man.

Authors:  G Reinecke; R Pabst
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

8.  Generation of human monoclonal antibodies recognising membranous antigens of the lung adenocarcinoma cell line A549 using an AMeX immunohistostaining method.

Authors:  K Yoshinari; H Kimura; K Arai; I Sugawara; K Noda; M Kihara; H Misaki; Y Yamaguchi
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

9.  The Reed-Sternberg cell/lymphocyte rosette. I. Properties of rosettes formed between Hodgkin's cell lines and allogeneic lymphocytes.

Authors:  D J Flavell; D H Wright
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

10.  Early involvement of the bronchi in patients with malignant lymphoma.

Authors:  C J Gallagher; G K Knowles; J A Habeshaw; M Green; J S Malpas; T A Lister
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.